Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...

Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

In a Senate hearing, Senator Bernie Sanders pushed Robert F. Kennedy Jr. again on his past support for unsupported claims ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

The Trump administration is poised to supercharge America’s appetite for supplements.

Robert F Kennedy Jr and Sen Bernie Sanders had a clash over the senator's links to Big Pharma as Trump's health nominee came ...

The recent Senate confirmation hearings for Robert F. Kennedy Jr. presented a striking scene that would confuse a time ...

I have been seeking recovery from alcohol, heroin and pharmaceutical opioid use disorders since late 2013. The treatment system is fraught with barriers, especially so if you’re ...

The company started the first phrase of its operation in the city in January at the David Lust Accelerator Building on the Elevate Rapid City campus.

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

While the Chicago metropolitan area is not a major life sciences hub, a recent Cushman & Wakefield report predicts the Chicago market should be a growth spot in the coming years. Chicago Biomedical ...